Brand Name Wilson Wolf Cell Culture Products for Adoptive Cell Therapy

Closed Solicitation Posted

Solicitation number
75N91024-CSS-6900011
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Rockville, Maryland 20850, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions (OA) is issuing a Request for Quote (RFQ) for the procurement of brand name Wilson Wolf cell culture products to support the NCI Surgery Branch's adoptive cell transfer therapy program for cancer patients. The required products must be manufactured in accordance with good manufacturing practices (GMP) and approved by the FDA. The solicitation will be awarded as a firm-fixed-price contract for a 12-month base period with four 1-year option periods. Quotes are due by June 21, 2024, and the award will be made to the lowest-priced technically acceptable offer. The requirement has a North American Industry Classification System (NAICS) code of 334516 - Analytical Laboratory Instrument Manufacturing.

This is an unrestricted competition, and no set-aside designations apply. The anticipated award is a single contract, but the solicitation does not specify any potential incumbent contractors or a budget range. The required quantities and delivery schedule for the Wilson Wolf cell culture products, including G-Rex100 (450 mL) and G-Rex100M (1,000 mL) models, are not explicitly stated. The place of performance is Potomac, MD 20850, USA.

Notice text

National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions (OA) 

This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with (FAR Part 13– Simplified Acquisition Procedures / FAR 13.5 - Simplified Procedures for Certain Commercial Products and Commercial Services). This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-02 (12/22/2023). 

The requirement’s suggested North American Industry Classification System (NAICS) code is 334516 – Analytical Laboratory Instrument Manufacturing with a size standard of 1000 Employees.

One Firm-Fixed-Priced award is anticipated to be made as a result of this solicitation.   

***PLEASE REVIEW THE ATTACHED DOCUMENTS*** 
 

Files

File Type Posted
CSS BN 75N91024 -CSS-6900011.pdf PDF
FAR 52.212-3 (MAY 2014).pdf PDF
FAR 52.204-24 (NOV 2021).pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Combines Synopsis Solicitation- Automated Spatial NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
NOI - 4D-Nucleofector Core Unit and X Unit NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside
Reagents and consumables for Roche immunostainers Bethesda, Maryland 20892, United States · NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
NCSS - Bioruptor Pico Sonication Device NAICS 334516 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors